Non-Current Assets

Royalty Pharma·Balance Sheet Statement·16 metrics

Breakdown

Loading...

Metrics

Gross loans

Purchased Credit Deteriorated Loans

Deferred Tax Assets and Other Non-Current Assets

Equipment Installment Plan Receivables (Non-Current), Net

Equity method investments

Equity Securities (FV-NI) - Non-Current

Equity Securities (Non-Current)

Available-for-sale securities

Total investments

Goodwill

Long-term marketable securities

Long-term financing receivables (net of allowances of $27 in 2026 and $34 in 2025)

Other non-current assets

Other non-current assets

Software and Technology Licenses, Net

Total assets